Cargando…
Phosphodiesterase 4 inhibitor plus metformin is superior to metformin alone for the treatment of polycystic ovary syndrome: A rat model study
The role of metformin in the management of polycystic ovary syndrome (PCOS) and PCOS-related obesity remains controversial. Recent research on the treatment of PCOS-related obesity investigated novel therapeutic agents with the potential to work synergistically with metformin. The aim of the present...
Autores principales: | Tohma, Yusuf Aytac, Onalan, Gogsen, Tepeoglu, Merih, Bayraktar, Nilufer, Colak, Eser, Ozcimen, Emel Ebru, Zeyneloglu, Hulusi Bulent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447905/ https://www.ncbi.nlm.nih.gov/pubmed/30988783 http://dx.doi.org/10.3892/etm.2019.7428 |
Ejemplares similares
-
Is placental KISS-1 expression associated with first trimester abortion spontaneous?
por: Colak, Eser, et al.
Publicado: (2020) -
Fetal rhabdomyoma with maternal tuberous sclerosis that almost completely filled the left ventricle at an early gestational week
por: Çolak, Eser, et al.
Publicado: (2021) -
Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis
por: Zeng, Huamin, et al.
Publicado: (2023) -
Comparison of exenatide alone or combined with metformin versus metformin in the treatment of polycystic ovaries: a systematic review and meta-analysis
por: Hu, Yan, et al.
Publicado: (2023) -
Human Menopausal Gonadotropin versus Recombinant FSH in Polycystic
Ovary Syndrome Patients Undergoing In Vitro Fertilization
por: Figen Turkcapar, Ayse, et al.
Publicado: (2013)